Age-adjusted high-dose chemotherapy and autologous stem cell transplant in elderly and fit primary CNS lymphoma patients
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Age-adjusted high-dose chemotherapy and autologous stem cell transplant in elderly and fit primary CNS lymphoma patients ; volume:19 ; number:1 ; day:29 ; month:3 ; year:2019 ; pages:1-7 ; date:12.2019
BMC cancer ; 19, Heft 1 (29.3.2019), 1-7, 12.2019
- Creator
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-019-5473-z
- URN
-
urn:nbn:de:101:1-2019042020034946328594
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:54 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Schorb, Elisabeth
- Finke, Jürgen
- Ihorst, Gabriele
- Kasenda, Benjamin
- Fricker, Heidi
- Illerhaus, Gerald
- SpringerLink (Online service)
Other Objects (12)
High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study)
Molekulare Mechanismen der Entstehung von B-Zell-Lymphomen des Menschen
Ein solid-phase-Radioimmunoassay zum Nachweis des Epstein-Barr-Virus-assoziierten Frühantigen-Komplexes (Early Antigen)
Informationsbroschüre für Patienten vor allogener Knochenmark-, Blutstammzelltransplantation
High-dose chemotherapy and autologous stem cell transplant compared with conventional chemotherapy for consolidation in newly diagnosed primary CNS lymphoma—a randomized phase III trial (MATRix)
Therapy response of glucocorticoid-refractory acute GVHD of the lower intestinal tract
Therapy response of glucocorticoid-refractory acute GVHD of the lower intestinal tract
Age-adjusted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy with R-MP as first-line treatment in elderly primary CNS lymphoma patients – the randomized phase III PRIMA-CNS trial
High-dose chemotherapy and autologous stem cell transplant compared with conventional chemotherapy for consolidation in newly diagnosed primary CNS lymphoma—a randomized phase III trial (MATRix)
A prospective single-center study on CNI-free GVHD prophylaxis with everolimus plus mycophenolate mofetil in allogeneic HCT
A prospective single-center study on CNI-free GVHD prophylaxis with everolimus plus mycophenolate mofetil in allogeneic HCT
Ruxolitinib in GvHD (RIG) study: a multicenter, randomized phase 2 trial to determine the response rate of Ruxolitinib and best available treatment (BAT) versus BAT in steroid-refractory acute graft-versus-host disease (aGvHD) (NCT02396628)
High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study)
Molekulare Mechanismen der Entstehung von B-Zell-Lymphomen des Menschen
Ein solid-phase-Radioimmunoassay zum Nachweis des Epstein-Barr-Virus-assoziierten Frühantigen-Komplexes (Early Antigen)
Informationsbroschüre für Patienten vor allogener Knochenmark-, Blutstammzelltransplantation
High-dose chemotherapy and autologous stem cell transplant compared with conventional chemotherapy for consolidation in newly diagnosed primary CNS lymphoma—a randomized phase III trial (MATRix)
Therapy response of glucocorticoid-refractory acute GVHD of the lower intestinal tract
Therapy response of glucocorticoid-refractory acute GVHD of the lower intestinal tract
Age-adjusted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy with R-MP as first-line treatment in elderly primary CNS lymphoma patients – the randomized phase III PRIMA-CNS trial
High-dose chemotherapy and autologous stem cell transplant compared with conventional chemotherapy for consolidation in newly diagnosed primary CNS lymphoma—a randomized phase III trial (MATRix)
A prospective single-center study on CNI-free GVHD prophylaxis with everolimus plus mycophenolate mofetil in allogeneic HCT
A prospective single-center study on CNI-free GVHD prophylaxis with everolimus plus mycophenolate mofetil in allogeneic HCT
Ruxolitinib in GvHD (RIG) study: a multicenter, randomized phase 2 trial to determine the response rate of Ruxolitinib and best available treatment (BAT) versus BAT in steroid-refractory acute graft-versus-host disease (aGvHD) (NCT02396628)
High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study)
Molekulare Mechanismen der Entstehung von B-Zell-Lymphomen des Menschen
Ein solid-phase-Radioimmunoassay zum Nachweis des Epstein-Barr-Virus-assoziierten Frühantigen-Komplexes (Early Antigen)
Informationsbroschüre für Patienten vor allogener Knochenmark-, Blutstammzelltransplantation
High-dose chemotherapy and autologous stem cell transplant compared with conventional chemotherapy for consolidation in newly diagnosed primary CNS lymphoma—a randomized phase III trial (MATRix)
Therapy response of glucocorticoid-refractory acute GVHD of the lower intestinal tract
Therapy response of glucocorticoid-refractory acute GVHD of the lower intestinal tract
Age-adjusted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy with R-MP as first-line treatment in elderly primary CNS lymphoma patients – the randomized phase III PRIMA-CNS trial
High-dose chemotherapy and autologous stem cell transplant compared with conventional chemotherapy for consolidation in newly diagnosed primary CNS lymphoma—a randomized phase III trial (MATRix)
A prospective single-center study on CNI-free GVHD prophylaxis with everolimus plus mycophenolate mofetil in allogeneic HCT
A prospective single-center study on CNI-free GVHD prophylaxis with everolimus plus mycophenolate mofetil in allogeneic HCT